Article
Establishment of an ulcerative colitis model using colon organoids derived from human induced pluripotent stem cells
26 Sept 2024
Abstract excerpt
The etiology of inflammatory bowel disease (IBD) is complex, with much room for a greater understanding and development of improved therapies. Therefore, establishing a reliable IBD model is crucial for future advancements. In this study, human induced pluripotent stem (iPS) cell-derived colon organoids (hiPSC-COs) were treated with a combination of tumor necrosis factor alpha (TNF-α), interferon-gamma (IFN-γ),...
Topics
Join the communities discussing this publication.
